Erasca Raises $200 Million To Combat Cancer
By Noah Long ● Apr 27, 2020
Erasca, a company on a mission to erase cancer, announced the completion of a $200 million Series B financing round co-led by ARCH Venture Partners and Cormorant Asset Management.